U.S., Aug. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07767552) titled 'Mazdutide for Remission of Type 2 Diabetes: Multicentre, Double Blind, Randomised, Placebo Controlled Trial' on Aug. 11.
Brief Summary: The purpose of this study is to investigate and efficacy of Mastitide for diabetes remission in Chinese type 2 diabetic subjects with poor glycemic control on diet or exercise therapy alone or metformin/sodium-glucose cotransporter (SGLT2) inhibitor monotherapy.
Study Start Date: Sept. 30
Study Type: INTERVENTIONAL
Condition:
Diabetes Mellitus, Type 2
Intervention:
DRUG: Mazdutide
GLP-1 receptor/glucagon receptor (GLP-1R/GCGR) dual agonist, administered by subcutaneous injection once weekly u...